A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

Clinical trial NCT06765317 · RECRUITING

Trial details

NCT number: NCT06765317
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell Lymphoma

Start date: 2025-01-16
Primary completion: 2028-01-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.